Cancer is a disease of older adults, with approximately 50% of cancer cases and 70% of cancer-related deaths occurring in individuals older than 65 years.1 Older adults are also the fastest-growing portion of the general population worldwide,2 which suggests that the incidence of cancer in this age group will continue to increase. Managing cancer in older adults poses a significant challenge to oncologists and health care systems because they represent a very heterogeneous population with organ-specific physiological changes and a diverse burden of functional impairments, comorbidities, polypharmacy, geriatric syndromes, and cognitive, nutritional, and psychological issues. All these factors may increase the risk of adverse events from anticancer treatments and complicate decision-making. In addition, the basis of evidence to guide the management of cancer in this group is limited, as therapeutic trials tend to enroll a very select population of patients.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Biganzoli L, McCartney A, Battisti NML. Expanding the Scope of Geriatric Assessment for the Management of Cancer in Older Adults. JAMA Oncol. 2020;6(2):204–205. doi:10.1001/jamaoncol.2019.4708
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: